Oncolytic Viruses

od Springer US
Stan: Nowy
509,86 zł
Zawiera podatek VAT, darmowa dostawa
Springer US Oncolytic Viruses
Springer US - Oncolytic Viruses

Podoba Ci się ten produkt? Przekaż dalej!

509,86 zł zawiera VAT
Dostępnych sztuk: 1 Dostępnych tylko 1 sztuk Dostępnych ponad 10 sztuk
Dostawa: między czwartek, 14 lipca 2022 a poniedziałek, 18 lipca 2022
Sprzedaż i wysyłka: Dodax

Opis

This book aims to provide a guide for virologists, translational researchers, and clinicians in the field of cancer research by providing reference protocols and methodologies from vector development through clinical translation.   Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.


 Authoritative and cutting-edge, Oncolytic Viruses: Methods and Protocols aims to ensure successful results in the further study of this vital field.

Dalsza informacja

Adnotacja do ilustracji:
16 SW-Abb., 48 Farbabb., 15 Farbtabellen
Język:
Angielski
Spis treści:

1. Introduction to Oncolytic Virotherapy



Christine E. Engeland and John C. Bell



 



2. Methods for Modification of Therapeutic Viruses 



Claudia AP Hill, Luca Bau, and Robert Carlisle



 



3. Tumor Targeting of Oncolytic Adenoviruses using Bispecific Adapter Proteins



Julia Niemann and Florian Kühnel



 



4. Development of Entry-targeted Oncolytic Measles Viruses



Michael D. Mühlebach and Roberto Cattaneo



 



5. Insert Stability and In Vivo Testing of MicroRNA-Detargeted Oncolytic Picornaviruses



Autumn J Schulze



 



6. Ex vivo Virotherapy with Myxoma Virus to Treat Cancer



Nancy Y. Villa, Lina S. Franco, and Grant McFadden



 



7. Immunomodulation in Oncolytic Measles Virotherapy



Laura Dietz and Christine E. Engeland



 



8. A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death



Tiphaine  Delaunay,  Carole  Achard,  Marc  Grégoire,  Frédéric  Tangy,  Nicolas Boisgerault, and Jean-François Fonteneau



 



9. Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation



Gayathri Vijayakumar and Dmitriy Zamarin



 



10. Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue



Krishna Das, Carles Urbiola, Bart Spiesschaert, Philipp Mueller, and Guido Wollmann



 



11. Immunohistochemistry for Tumor-infiltrating Immune Cells after Oncolytic Virotherapy



Dipongkor Saha and Samuel D. Rabkin



 



12. Detection of Tumor Antigen-specific T-cell Responses after Oncolytic Vaccination



Jonathan G. Pol, Byram W. Bridle, and Brian D. Lichty



 



13. Evaluation of Oncolytic Virus Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models



Rūta Veinalde



 



14. Delivery of Oncolytic Reovirus by Cell Carriers



Elizabeth J. Ilett



 



15. In Vivo Bioimaging for Monitoring Intratumoral Virus Activity



Liesa-Marie Schreiber, Carles Urbiola, Patrik Erlmann, and Guido Wollmann



 



16. Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 virus: Using a Bladder Tumour Precision-cut Slice Model System to Assess Viral Efficacy



 



Kate Relph, Nicola Annels, Chris Smith, Marcos Kostalas, and Hardev Pandha



 



17. Use of Liquid Patient Ascites Fluids as a Pre-clinical Model for Oncolytic Virus Activity



Eleanor M. Scott, Sally Frost, Hena Khalique, Joshua D. Freedman, Len W. Seymour, and Janet Lei-Rossmann



 



18. Generating Primary Models of Human Cancer to Aid in the Development of Clinically-relevant Oncolytic Viruses



Brian A. Keller, Marie-Ève Wedge, Abera Surendran, and Carolina S. Ilkow



 



19. Considerations for Clinical Translation of MG1 Maraba Virus



Caroline J. Breitbach



 



20. Fluorescence in Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-treated Human Brain Tumors



Irina Kiprianova, Alexandra Just, Barbara Leuchs, Jean Rommelaere, and Assia L. Angelova



 



21. Mathematical Modeling of Oncolytic Virotherapy



Johannes P.W. Heidbuechel, Daniel Abate-Daga, Christine E. Engeland, and Heiko Enderling



 



Edycja:
1st ed. 2020
Liczba stron:
329
Redaktor:
Engeland, Christine E.;Engeland
Uwagi:
Includes cutting-edge methods and protocols


Provides step-by-step detail essential for reproducible results


Contains key notes and implementation advice from the experts

Nośnik:
Miękka oprawa
Publisher:
Springer US

Dane podstawowe

Rodzaj produktu:
Książka z miękką oprawą
Wymiary opakowania:
0.254 x 0.177 x 0.021 m; 0.748 kg
GTIN:
09781493997961
DUIN:
UPBD1JAFJ6Q
509,86 zł
Na naszej stronie wykorzystujemy pliki cookies, aby strona była jeszcze bardziej funkcjonalna i przyjazna użytkownikowi. Prosimy kliknąć „Akceptuj cookies”! Więcej informacji znajdziesz w Polityce prywatności.